Literature DB >> 2720846

Characteristics of the gastrointestinal absorption of morphine in rats.

T Tan, M Kuramoto, T Takahashi, H Nakamura, Y Nakanishi, Y Imasato, H Yoshimura.   

Abstract

The absorption characteristics of morphine were investigated by using rat gastrointestine. Absorption and transport experiments were carried out by the in situ loop and the in vitro everted sac methods, respectively. Brush border membrane vesicles (BBMVs) were used for uptake experiments. Morphine and its metabolites, morphine-3-glucuronide (M-3-G), and morphine-6-glucuronide (M-6-G), in biological samples were simultaneously determined by high-performance liquid chromatography (HPLC) with ultraviolet (UV) detection and electrochemical detection. In the in situ loop method, morphine was well absorbed in the order of jejunal site greater than duodenal site greater than ileal site greater than middle intestinal site greater than rectal site, but it was poorly absorbed from the stomach. In each of the everted duodenal and jejunal sacs, 2,4-dinitrophenol, a metabolic inhibitor, inhibited the transport of morphine from the mucosal side to the serosal side. Further, HgCl2 pretreatment reduced the absorption of morphine from the duodenal and the jejunal loops. The initial uptake of morphine by BBMVs was stimulated in the presence of an H+ gradient (inner pH 7.5 and outer pH 5.0) and an overshoot phenomenon was observed. The initial uptake showed concentration dependence, i.e., it was saturable. Results obtained in this study indicate that carrier-mediated transport stimulated by the H+ gradient is partly involved in the duodeno-jejunal absorption of morphine, although morphine is passively absorbed from other sites.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2720846     DOI: 10.1248/cpb.37.168

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  6 in total

1.  Transepithelial transport of diphenhydramine across monolayers of the human intestinal epithelial cell line Caco-2.

Authors:  H Mizuuchi; T Katsura; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

2.  Bariatric Surgery Patients' Response to a Chronic Pain Rehabilitation Program.

Authors:  Anilga Tabibian; Karen B Grothe; Manpreet S Mundi; Todd A Kellogg; Matthew M Clark; Cynthia O Townsend
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

3.  Increased intravenous morphine self-administration following Roux-en-Y gastric bypass in dietary obese rats.

Authors:  Jessica M Biegler; Christopher S Freet; Nelli Horvath; Ann M Rogers; Andras Hajnal
Journal:  Brain Res Bull       Date:  2015-08-21       Impact factor: 4.077

Review 4.  Pharmacology of morphine in obese patients: clinical implications.

Authors:  Célia Lloret Linares; Xavier Declèves; Jean Michel Oppert; Arnaud Basdevant; Karine Clement; Christophe Bardin; Jean Michel Scherrmann; Jean Pierre Lepine; Jean François Bergmann; Stéphane Mouly
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

5.  Age-dependent intestinal absorption of valproic acid in the rat.

Authors:  A Cato; G M Pollack; K L Brouwer
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

Review 6.  The role of the gut microbiome in opioid use.

Authors:  Michelle Ren; Shahrdad Lotfipour
Journal:  Behav Pharmacol       Date:  2020-04       Impact factor: 2.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.